LifeStance Health Income Statement (2020-2025) | LFST

Income Statement Jun2020 Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 45.45M101.98M143.13M160.55M173.84M190.00M203.09M209.53M217.56M229.36M252.59M259.58M262.89M280.60M300.44M312.33M312.72M325.48M332.97M345.31M363.81M
Cost of Revenue 31.27M68.85M99.13M109.34M121.78M135.75M148.89M149.70M157.27M166.67M182.99M186.61M186.69M197.29M205.71M214.53M212.29M
Gross Profit 14.18M33.13M44.00M51.21M52.05M54.25M54.20M59.83M60.29M62.69M69.60M72.97M76.21M83.31M94.73M97.81M100.43M
Operating items
Selling, General & Administrative 8.64M19.53M32.65M85.48M162.94M152.65M103.37M103.56M81.25M89.82M84.63M101.85M130.94M93.37M88.93M95.15M85.27M93.71M94.43M97.38M95.61M
Other Operating Expenses 36.71M79.76M111.36M122.11M135.56M151.10M164.58M166.44M175.15M185.56M202.06M206.14M206.31M219.51M228.28M233.12M227.41M230.72M236.94M250.89M260.78M
Operating Expenses 45.35M99.29M144.01M207.59M298.50M303.75M267.95M270.00M256.40M275.37M286.68M307.99M337.25M312.87M317.21M328.28M312.68M324.42M331.37M348.26M356.40M
Operating Income 0.10M2.69M-0.88M-47.05M-124.67M-113.76M-64.85M-60.47M-38.84M-46.01M-34.09M-48.41M-74.36M-32.27M-16.77M-15.95M0.05M1.06M1.60M-2.95M7.41M
EBIT 0.10M2.69M-0.88M-47.05M-124.67M-113.76M-64.85M-60.47M-38.84M-46.01M-34.09M-48.41M-74.36M-32.27M-16.77M-15.95M0.05M1.06M1.60M-2.95M7.41M
Non-operating items
Non Operating Income -5.82M-7.06M-10.56M-26.78M-4.54M-4.88M-4.15M-7.33M-3.37M-7.70M-4.19M-3.61M-3.61M-6.04M-3.96M-6.67M-5.43M-9.94M-3.07M-2.99M-2.84M
Net income details
EBT -5.71M-4.37M-11.44M-73.82M-129.20M-118.64M-69.00M-67.80M-42.21M-53.72M-38.28M-52.02M-77.97M-38.32M-20.73M-22.62M-5.38M-8.88M-1.47M-5.94M4.57M
Tax Provisions 1.37M-1.07M-2.76M-3.79M-8.75M-10.61M-6.68M0.92M-4.35M-7.06M-4.04M-6.54M-16.39M6.64M0.36M0.66M0.57M-0.81M-2.18M-2.15M3.50M
Profit After Tax -4.34M-3.29M-8.68M-70.03M-120.45M-108.03M-62.33M-68.73M-37.85M-46.66M-34.24M-45.48M-61.58M-44.96M-21.10M-23.28M-5.96M-7.11M0.71M-3.79M1.08M
Income from Continuing Operations -7.08M-3.29M-8.68M-70.03M-120.45M-108.03M-62.33M-68.73M-37.85M-46.66M-34.24M-45.48M-61.58M-44.96M-21.10M-23.28M-5.96M-8.07M0.71M-3.79M1.08M
Consolidated Net Income -7.08M-3.29M-8.68M-70.03M-120.45M-108.03M-62.33M-68.73M-37.85M-46.66M-34.24M-45.48M-61.58M-44.96M-21.10M-23.28M-5.96M-8.07M0.71M-3.79M1.08M
Income towards Parent Company -7.08M-3.29M-8.68M-70.03M-120.45M-108.03M-62.33M-68.73M-37.85M-46.66M-34.24M-45.48M-61.58M-44.96M-21.10M-23.28M-5.96M-8.07M0.71M-3.79M1.08M
Preferred Dividend Payments 36.75M
Net Income towards Common Stockholders -4.34M-3.29M-45.43M-70.03M-120.45M-108.03M-62.33M-68.73M-37.85M-46.66M-34.24M-45.48M-61.58M-44.96M-21.10M-23.28M-5.96M-7.11M0.71M-3.79M1.08M
Additional items
EPS (Basic) 0.01-0.01-0.15-0.22-350.77-0.32-0.18-0.19-0.11-0.13-0.09-0.13-0.17-0.12-0.06-0.06-0.02-0.02-0.01
EPS (Weighted Average and Diluted) -0.22-329.84-0.18-0.19-0.11-0.13-0.09-0.13-0.17-0.12-0.06-0.06-0.02-0.02-0.01
Shares Outstanding (Weighted Average) 297.24M0.30M0.31M0.31M0.34M0.33M0.35M0.35M0.36M355.28M360.90M363.16M372.48M367.46M376.33M379.43M380.36M379.15M
Shares Outstanding (Diluted Average) 0.33M0.35M0.35M0.36M355.28M360.90M363.16M372.48M367.46M376.33M379.43M380.36M379.15M
EBITDA -4.34M-3.29M-8.68M-70.03M-120.45M-108.03M-62.33M-68.73M-34.67M-46.57M-35.51M-43.33M-61.35M-47.04M-20.51M-23.52M-7.83M-6.95M0.39M-4.06M0.73M
Interest Expenses 5.56M6.42M8.63M23.17M3.50M3.60M3.44M7.13M4.19M5.17M5.09M5.12M5.48M5.53M5.90M5.82M5.41M9.40M3.07M2.90M2.81M
Tax Rate -23.98%24.59%24.13%5.13%6.77%8.94%9.67%-1.36%10.31%13.14%10.55%12.58%21.02%-17.34%-1.75%-2.90%-10.68%9.08%148.23%36.20%76.44%